WILLIAM FISHER to Adenocarcinoma
This is a "connection" page, showing publications WILLIAM FISHER has written about Adenocarcinoma.
Connection Strength
0.794
-
Developing a tissue resource to characterize the genome of pancreatic cancer. World J Surg. 2009 Apr; 33(4):723-31.
Score: 0.092
-
Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications. World J Surg. 2005 Mar; 29(3):297-305.
Score: 0.070
-
Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCR. J Surg Res. 2004 Jun 15; 119(2):130-7.
Score: 0.066
-
Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens. Ann Clin Lab Sci. 2023 Nov; 53(6):847-860.
Score: 0.063
-
Perineural Invasion by an Intraductal Papillary Mucinous Neoplasm of Pancreas: A Case Report of an Unusual and Unreported High-Risk Feature of Malignant Progression. Ann Clin Lab Sci. 2022 Sep; 52(5):838-842.
Score: 0.059
-
Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma. Int J Pancreatol. 1998 Dec; 24(3):169-80.
Score: 0.045
-
Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 2017 09; 162(3):557-567.
Score: 0.041
-
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Rep. 2016 Feb 02; 14(4):907-919.
Score: 0.037
-
Pancreatic cancer disparities in African Americans. Pancreas. 2015 May; 44(4):522-7.
Score: 0.035
-
The hypofunctional effect of P335L single nucleotide polymorphism on SSTR5 function. World J Surg. 2011 Aug; 35(8):1715-24.
Score: 0.027
-
Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemona?ve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116. J Thorac Oncol. 2010 Nov; 5(11):1815-20.
Score: 0.026
-
Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg. 2010 Nov; 14(11):1832-7.
Score: 0.025
-
Basic principles and technologies for deciphering the genetic map of cancer. World J Surg. 2009 Apr; 33(4):615-29.
Score: 0.023
-
Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res. 2009 Oct; 156(2):189-98.
Score: 0.023
-
Diabetes enhances growth of pancreatic carcinoma cells. Surgery. 1988 Aug; 104(2):431-6.
Score: 0.022
-
Preoperative prediction of complete resection in pancreatic cancer. J Surg Res. 2008 Jun 15; 147(2):216-20.
Score: 0.022
-
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther. 2008 Feb; 7(2):286-96.
Score: 0.021
-
Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther. 2008 Mar; 7(3):419-23.
Score: 0.021
-
Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer. 2004 Nov 15; 101(10):2341-50.
Score: 0.017
-
Somatostatin receptor gene transfer inhibits established pancreatic cancer xenografts. J Surg Res. 2003 Nov; 115(1):41-7.
Score: 0.016
-
Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo. Surgery. 1997 Apr; 121(4):392-7.
Score: 0.010
-
Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide. Surgery. 1996 Aug; 120(2):234-40; discussion 240-1.
Score: 0.010
-
Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res. 1996 Jun; 63(1):310-3.
Score: 0.009
-
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells. PLoS One. 2014; 9(9):e106289.
Score: 0.008
-
Gefitinib plus celecoxib in chemotherapy-na?ve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group. J Thorac Oncol. 2008 Apr; 3(4):374-9.
Score: 0.005